RecruitingNot ApplicableNCT06529016

Using Dichoptic Therapy to Treat Intermittent Exotropia


Sponsor

Virginia Commonwealth University

Enrollment

20 participants

Start Date

Jul 26, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

Intermittent exotropia is difficult to treat. The mainstay of treatment involves surgery, and in one long-term study authors found that as many as 60% of IXT required at least one re-operation.Patching of the non-dominant eye has also been tested in a large, multi-center randomized control trial and was not found to have a large benefit. More non-surgical treatment modalities are critical to improve the care in this condition.


Eligibility

Min Age: 4 YearsMax Age: 7 Years

Inclusion Criteria4

  • Diagnosed with IXT
  • one eye that is their preferred eye
  • ages 4-7
  • distance control scores of <= 4

Exclusion Criteria4

  • distance control scores of 5
  • patients with visual acuity with vision that is worse in one eye by greater than two lines
  • no preferred eye
  • patients who would be unable to tolerate wearing the headset for 1 hour/day, 6 days/week, for 12 weeks.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICELuminopia, a virtual reality headset

Subjects will be provided with the equipment to use in their homes for six hours usage per week (1 hour 6 days a week), for 12 weeks.

OTHERPaper pre- survey

Pre-survey to be completed by the parent and child. Questions may be skipped. Survey developed by the study team

OTHERPaper Survey

Post-survey to be completed by the parent and child. Questions may be skipped. Survey developed by the study team


Locations(1)

Virginia Commonwealth University

Richmond, Virginia, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06529016